Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-008193

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Douglas M Van Oort
Officer — Chairman and CEO
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 9:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 2, 2017M200,000$1.71A1,875,000D
Common StockF3,F4Feb 2, 2017F42,015$8.14D1,832,985D
Common StockF1holding———187,500IConundrum Capital Partners
Common StockF2holding———1,675,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)$1.71Feb 2, 2017X200,000DFeb 14, 2013Feb 14, 2017Common Stock200,0000D
Stock Option (Right to Buy)F5$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock472,527472,527D

Explanation of responses